Home » Internet » Results for the six months and year ended 31 December 2020 – Short form announcement
Results for the six months and year ended 31 December 2020 – Short form announcement Posted by PublisherInternet Thursday, 18. February 2021
Sibanye-Stillwater (Tickers JSE: SSW and NYSE: SBSW – https://www.commodity-tv.com/ondemand/companies/profil/sibanye-stillwater-ltd/) is pleased to report operating and financial results for the six months ended 31 December 2020, and reviewed condensed consolidated provisional financial statements for the year ended 31 December 2020.
SALIENT FEATURES FOR THE SIX MONTHS AND YEAR ENDED 31 DECEMBER 2020
Profit attributable to owners of Sibanye-Stillwater increased to R29,312m (US$1,781m) from R62m (US$5m) for 2019
Alcon Inc. Investors: Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.
1
The drop, formerly prescribed as Pazeo, joins Alcon s over-the-counter ocular allergy portfolio to meet a variety of patient needs
The expansion of the Pataday portfolio of products will strengthen Alcon s leadership position in the U.S. eye allergy OTC market
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Pataday
Once Daily Relief Extra Strength (
olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (OTC). As Alcon s third Rx-to-OTC switch in the past twelve months, Pataday Once Daily Relief Extra Strength joins the #1 selling OTC eye allergy relief brand and is poised to help the company maintain its leadership position in the ocular all